CYTOKINETICS INC — Director's Dealing 2020

Jul 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-07-07

Reporting Person: SMITH SANDFORD D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-07	Common Stock	M	5232	$6.21	Acquired	5232	Direct
2020-07-07	Common Stock	S	5232	$27.0	Disposed	0	Direct
2020-07-07	Common Stock	M	6510	$6.72	Acquired	6510	Direct
2020-07-07	Common Stock	S	6510	$26.0	Disposed	0	Direct
2020-07-08	Common Stock	M	1434	$6.21	Acquired	1434	Direct
2020-07-08	Common Stock	S	1434	$27.0	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-07	Non-Qualified Stock Option (right to buy)	$6.21	M	5232	Disposed	2025-05-20	Common Stock (5232)	Direct
2020-07-08	Non-Qualified Stock Option (right to buy)	$6.21	M	1434	Disposed	2025-05-20	Common Stock (1434)	Direct
2020-07-07	Non-Qualified Stock Option (right to buy)	$6.72	M	6510	Disposed	2024-01-02	Common Stock (6510)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020.